| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |